APA
SVA

American Portfolios Advisors’s Sinovac Biotech, Ltd SVA Stock Holding History

American Portfolios Advisors’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,200
Closed -$8.33K – 2705
2018
Q4 		$8.33K Hold
1,200
– – ﹤0.01% 1694
2018
Q3 		$9.14K Hold
1,200
– – ﹤0.01% 1780
2018
Q2 		$8.95K Hold
1,200
– – ﹤0.01% 1763
2018
Q1 		$10.3K Hold
1,200
– – ﹤0.01% 1624
2017
Q4 		$9.46K Buy
+1,200
New +$8.98K ﹤0.01% 1587

Other funds holding SVA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American Portfolios Advisors's SVA Position: Q1 2019 in Review

American Portfolios Advisors sold out of Sinovac Biotech, Ltd (SVA) in Q1 2019, closing a stake of 1,200 shares — an estimated $8.33K sold.

American Portfolios Advisors first reported a position in SVA in Q4 2017 and held it in 5 quarters. The position peaked at $10.3K in Q1 2018. 25 funds tracked by Wall St. Rank hold SVA as of Q1 2019.

  • American Portfolios Advisors reported no remaining Sinovac Biotech, Ltd position as of Q1 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 1,200 Sinovac Biotech, Ltd shares in Q1 2019, an estimated $8.33K.
  • American Portfolios Advisors first reported a position in Sinovac Biotech, Ltd in Q4 2017 and held it in 5 quarters.
  • American Portfolios Advisors's Sinovac Biotech, Ltd position peaked at $10.3K in Q1 2018.
  • 25 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2019.

Based on American Portfolios Advisors's 13F filing for Q1 2019, filed 24 Mar 2023.